Fact CheckerSign in

NCT05168202CompletedPhase 1

A study to assess the effect of CC-95251 alone and in combination with anti-cancer drugs in subjects with Acute Myeloid Leukemia and Myelodysplastic Syndromes

Source: EU CTIS (euclinicaltrials.eu) · Last updated 28 Aug 2024

Status (registry)
Completed
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
153 (actual)
First submitted
12 Dec 2023
Start date
5 Jan 2022
Lead sponsor
Celgene Corp.
NCT number
NCT05168202
EU CT number
2023-506117-22-00
EudraCT number
2021-002799-38

What you commit to

  • Study type: Interventional · Phase 1
  • Participants enrolled: 153
  • 18 sites in 5 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Sites (18)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Institut Catala d'Oncologia
Coordinator of this site? Confirm its status
BadalonaSpainCompleted
Hospital de la Santa Creu i Sant Pau
Coordinator of this site? Confirm its status
BarcelonaSpainCompleted
Hospital General Universitario Gregorio Marañón
Coordinator of this site? Confirm its status
MadridSpainCompleted
Hospital Universitario De Salamanca
Coordinator of this site? Confirm its status
SalamancaSpainCompleted
Hospital Universitario Marqués de Valdecilla
Coordinator of this site? Confirm its status
SantanderSpainCompleted
Institut Paoli-Calmettes
Coordinator of this site? Confirm its status
MarseilleFranceCompleted
Centre Hospitalier Universitaire de Nantes
Coordinator of this site? Confirm its status
NantesFranceCompleted
Centre Hospitalier Universitaire de Bordeaux
Coordinator of this site? Confirm its status
PessacFranceCompleted
Institut Universitaire du Cancer Toulouse - Oncopole
Coordinator of this site? Confirm its status
ToulouseFranceCompleted
Institut Gustave Roussy
Coordinator of this site? Confirm its status
VillejuifFranceCompleted
Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l
Coordinator of this site? Confirm its status
MeldolaItalyCompleted
ASST Grande Ospedale Metropolitano Niguarda
Coordinator of this site? Confirm its status
MilanItalyCompleted
Humanitas Research Hospital
Coordinator of this site? Confirm its status
RozzanoItalyCompleted
Helse Bergen HF
Coordinator of this site? Confirm its status
BergenNorwayCompleted
Oslo University Hospital HF
Coordinator of this site? Confirm its status
OsloNorwayCompleted
Sahlgrenska University Hospital-Vastra Gotalandsregionen
Coordinator of this site? Confirm its status
GoteborgSwedenCompleted
Karolinska University Hospital
Coordinator of this site? Confirm its status
HuddingeSwedenCompleted
Region Skane Skanes Universitetssjukhus
Coordinator of this site? Confirm its status
LundSwedenCompleted

This page is information, not medical advice. Discuss any trial with your doctor.